A detailed history of Polar Capital Holdings PLC transactions in Amgen Inc stock. As of the latest transaction made, Polar Capital Holdings PLC holds 381,938 shares of AMGN stock, worth $106 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
381,938
Previous 503,110 24.08%
Holding current value
$106 Million
Previous $157 Million 21.71%
% of portfolio
0.75%
Previous 0.96%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $37.5 Million - $40.9 Million
-121,172 Reduced 24.08%
381,938 $123 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $35.1 Million - $42.7 Million
133,764 Added 36.22%
503,110 $157 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $33.4 Million - $40.4 Million
124,354 Added 50.76%
369,346 $105 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $57.1 Million - $64.4 Million
223,272 Added 1027.96%
244,992 $70.6 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $365,582 - $453,881
-1,672 Reduced 7.15%
21,720 $5.84 Million
Q1 2023

Dec 13, 2023

BUY
$225.79 - $275.2 $377,520 - $460,134
1,672 Added 7.7%
23,392 $5.66 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $467,159 - $569,388
-2,069 Reduced 8.13%
23,392 $5.66 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $730,841 - $824,256
-3,256 Reduced 11.34%
25,461 $5.74 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $496,205 - $567,862
2,495 Added 9.51%
28,717 $6.46 Million
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $20.1 Million - $23.5 Million
-94,632 Reduced 78.3%
26,222 $5.58 Million
Q2 2021

Aug 16, 2021

BUY
$233.58 - $259.14 $12.2 Million - $13.6 Million
52,435 Added 76.64%
120,854 $29.5 Million
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $3.88 Million - $4.53 Million
-17,500 Reduced 20.37%
68,419 $17 Million
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $18.6 Million - $22.1 Million
85,919 New
85,919 $19.8 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.